/PRNewswire/ -- Cooler Heads, a pioneering medical device company, has closed an oversubscribed $11M Series A funding round to expand the manufacturing and...
SAN DIEGO, July 22, 2025 /PRNewswire/ -- Cooler Heads, a pioneering medical device company, has closed an oversubscribed $11M Series A funding round to expand the manufacturing and rollout of Amma™, the only FDA-cleared Portable Scalp Cooling System.Amma™ offers a continuous cooling system that eliminates the need for dry ice or frequent cap changes, making it a more accessible alternative to traditional methods. The Series A financing was led by Mutual Capital Partners, a Cleveland healthtech-focused venture capital fund, and contained participation from SHD Partners, Crescent Ridge VC, Cal Innovation Fund, NuFund, Robin Hood Ventures, Golden Seeds, HIP VC, and an unnamed strategic investor.Funds will be used to increase manufacturing capacity, expand the commercial team, and to develop the next generation of the product. Investors see Amma™ as a game-changer in cancer care, with the potential to improve the quality of life for thousands of patients. "Our investment in Cooler Heads reflects our confidence in the ability of this leadership team to make scalp cooling available wherever patients are getting chemotherapy.Cooler Heads is not only improving care for patients, but for the first time making this therapy low friction for infusion centers," said Liz Todia Zambory who led the Mutual Capital Partners team's investment.